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Abstract: Diabetic wound healing is associated with impaired function and reduced numbers of myofibroblasts, a heterogeneous cell population with varying capacities to promote repair. To determine
how diabetes alters myofibroblast composition, we performed flow cytometry and spatial tissue analysis of myofibroblast subsets throughout the healing process in diabetic (db/db) and control (db/+)
mouse skin. We observed reduced numbers of profibrotic SCA1+; CD34+; CD26+ myofibroblasts in
diabetic wounds five days after injury, with decreased expression of fibrosis-associated genes compared to myofibroblasts from db/+ mouse wounds. While the abundance of myofibroblasts remained
reduced in db/db mouse wounds compared to controls, the altered myofibroblast heterogeneity
and gene expression in diabetic mice was improved seven days after injury. The natural correction
of myofibroblast composition and gene expression in db/db wound beds temporally corresponds
with a macrophage phenotypic switch. Correlation analysis from individual wound beds revealed
that wound healing in control mice is associated with CD206+ macrophages, while the rescued
myofibroblast phenotypes in diabetic wounds are correlated with increased CD301b+ macrophage
numbers. These data demonstrate how diabetes impacts specific subsets of myofibroblasts and
indicate that signaling capable of rescuing impaired diabetic wound healing could be different from
signals that regulate wound healing under nonpathological conditions.
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1. Introduction
Wound healing requires communication between numerous tissue-resident and infiltrating cells [1,2]. Dynamic changes within these signaling networks help regulate three
overlapping phases that govern wound healing: inflammation, proliferation, and tissue
remodeling. Diabetes is associated with impaired wound healing that is characterized by
delayed early activation of proinflammatory immune cells and subsequent persistence
of proinflammatory immune cells at later time points after injury [3–6]. This hinders
the progression into the proliferation phase, preventing wound healing from occurring
efficiently.
Shortly after the injury, numerous cells produce proinflammatory factors that support
the infiltration of inflammatory macrophages and neutrophils [7–9]. These myeloid cells
clear foreign pathogens and cellular debris and perpetuate inflammation [2,7,10] before activating the initial processes that promote repair [11–13]. As inflammation resolves, changes
in the gene expression profile of local macrophages support entry into the proliferation
phase [10,12,14,15]. Macrophage-derived factors promote the migration and proliferation
of keratinocytes, fibroblasts, and endothelial cells to repair the injured tissue [11,13,15–17].
Activated fibroblasts, or myofibroblasts, are the leading producers of extracellular matrix
(ECM) molecules necessary to strengthen the repaired tissue [18–20]. Lineage tracing and
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cell surface profiling have defined multiple subsets of functionally distinct myofibroblasts in wound beds [21–25]. We have previously shown that myofibroblasts expressing
SCA1, CD34, and CD29 are enriched with the potential to generate mature ECM [23]. This
population is Engrailed-lineage traced and expresses CD26, characteristic of scar-forming
fibrogenic myofibroblasts in both mice and humans [22,23,26,27]. This population of myofibroblasts is diminished in wounds of aged mice and undergoes significant age-related
changes in its transcriptome [23], underscoring the need to understand how this population
is altered under different pathological conditions.
Diabetic wound healing is associated with reduced numbers of alpha-smooth muscle
actin (SMA)-expressing myofibroblasts and changes in myofibroblast gene expression that
contribute to reduced ECM deposition [28–32]. While impaired diabetic wound healing
can result in wounds that persist for months to years in humans [33], repair in diabetic mice
is typically delayed, with wounds closing by 14–28 days based on the original size and
location of the injury [34–36]. Recent reports have begun to characterize functional groups
of myofibroblasts that are present during different types of wound healing responses in
mice and humans [22,23,37–40], including multiple groups defining subsets of fibroblasts
in human diabetic wounds [39,40]. Though these single endpoint reports provide large
datasets that can reveal mechanisms that contribute to impaired healing, additional multiendpoint studies are needed to define how diabetes alters wound bed myofibroblast
composition and function over time and to define mechanisms that support repair in a
diabetic state.
In this study, we investigated how diabetes alters myofibroblast heterogeneity and
gene expression using diabetic db/db mice. We observed delayed appearance of fibrogenic
SCA1+; CD29+; CD26+ myofibroblasts in diabetic mouse wound beds compared to control
mice. This altered myofibroblast composition was associated with decreased gene expression of repair- and fibrosis-associated genes in day five wound beds. Surprisingly, seven
days after injury, the relative abundance of SCA1+; CD29+; CD26+ myofibroblasts became
more prevalent, and diabetes-associated changes in gene expression within this cellular
population were not detected. Correlation analyses from individual wound beds revealed
that a robust population of CD26- and SMA-expressing myofibroblasts were associated
with the emergence of CD206+ macrophages in control mice. However, the diminished
disease phenotype was positively correlated with the number of macrophages that express
CD301b. Our results demonstrate that myofibroblast heterogeneity and gene expression
in diabetic mice bias the wound environment towards a non-reparative state and that the
natural correction of the disease phenotype is observed with increased numbers of CD301b+
macrophages that have been shown to support the proliferation of SCA1+; CD29+; CD26+
myofibroblasts in control conditions [23]. These data reveal that the ability of diabetic mice
to heal may depend on different factors than what coordinates repair in control animals
and highlight the importance of identifying mechanisms that promote tissue repair in a
diabetic state.
2. Materials and Methods
2.1. Mice
Animal care and experiments were performed following the guidance of George
Washington University’s Institutional Animal Care and Use Committee (IACUC). Mice of
the B6.BKS(D)-Leprdb /J (Jackson Laboratories, Bar Harbor, ME, USA, Stock #000697; db/db
mice) strain with a spontaneous leptin receptor mutation resulting in hyperinsulinemia,
hyperglycemia, and obesity were used for these studies, and db/+ littermates were used
as controls. During the telogen phase of the hair cycle, male mice (7–9 weeks old) were
anesthetized, dorsal fur was shaved, and four full-thickness skin excision wounds were
inflicted by biopsy punch (Integra Miltex, Rietheim-Weilheim, Germany), 3–4 mm apart,
on either side of the spine between the shoulders and hips as previously described [23,41].
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2.2. Immunofluorescence and Wound Bed Analysis
After euthanasia, wounds were harvested, embedded in optimal cutting temperature
(O.C.T.) compound, frozen, and sectioned using a cryostat (Microm, Boise, ID, USA). To
identify the center of wounds, the entirety of the embedded tissue was sectioned from
wound edge to wound edge. Sequential tissue sections were distributed across approximately ten slides to allow the center of the wound to be identified on each slide. Tissue
cryosections of 16 or 40 µm thickness were fixed with 4% formaldehyde and stained
with the following antibodies: CD26 (Abcam, Waltham, MA, USA, 1:250; Novus, 1:50),
CD29 (R&D Systems, 1:50), CD45 (Biolegend, 1:500), CD206 (Biolegend, San Diego, CA,
USA 1:500), CD301b (eBioscience, San Diego, CA, USA, 1:100), ER-TR7 (Abcam, 1:500),
iNOS (Thermofisher, Waltham, MA, USA, 1:100), PU.1 (Cell Signaling, Danvers, MA, USA,
1:100), and SMA (Abcam, 1:400). For histological analysis of each wound, the two centralmost wound bed sections were imaged using Zeiss AxioImager M2 (Zeiss, Oberkochen,
Germany) with Orca camera (Hamamatsu, Hamamatsu, Japan), analyzed as described
below, and averaged together as a single wound bed value. The abundance of SMA+
and ER-TR7+ fibroblasts was calculated using the Color Range feature of Adobe Photoshop to determine the percentage of wound bed pixels occupied by fluorescent staining.
ECM proteins were quantified by the previously described corrected total fluorescence
calculation [42,43] using ImageJ software (National Institutes of Health, Bethesda, MD,
USA). Spatial mapping of fibroblast subsets based on CD45 (negative), CD26, and CD29
expression was performed in MATLAB as previously detailed [23]. Wound bed CD26 immunostaining was assessed by mean gray fluorescence (sum of pixel gray values divided
by the total number of pixels selected) of the wound bed within CD45-negative cells using
ImageJ. Cell counts were manually tabulated in ImageJ software.
2.3. Fluorescence-Activated Cell Sorting Analysis
Intact dorsal mouse skin or wound beds were harvested, minced, and digested using
Liberase TM to release single cells. Cells were resuspended in FACS staining buffer (1%
BSA in PBS with 2 mM EDTA) and stained with the following antibodies for 30 min on ice:
CD45-PE-Cy7 (eBioscience, 1:2000), CD31-APC-Fire750 (Biolegend 1:1000), CD29-Alexa700
(eBioscience, 1:400), CD34-Pacific Blue (BD Bioscience, 1:50), Sca1-V500 (eBioscience, 1:500),
CD26-PE-Cy7 (Biolegend, 1:500), CD9-APC (BD Bioscience, 1:100), and CD9-FITC (eBioscience, 1:100). Samples were analyzed on a BD Aria III with FACSDiva software (BD
Biosciences, San Jose, CA, USA), and gating and analyses were completed with FlowJo
software (BD Biosciences).
2.4. RNA Extraction and qRT-PCR
To determine differential gene expression between conditions, FACS-purified myofibroblasts were sorted into DMEM containing 10% FBS. Cells were pelleted by centrifugation. Using TRIzol LS (Invitrogen, Waltham, MA, USA), samples were digested and
phase-separated; RNA was extracted in the aqueous phase and purified using the RNeasy
Plus Micro Kit (Qiagen, Hilden, Germany). A Superscript III First-Strand Synthesis Kit
(Invitrogen) was used to generate cDNA proportionally to the isolated RNA. Gene targets
were amplified by qRT-PCR on a LightCycler 480 (Roche, Basel, Switzerland) with SYBR
PowerTrack Green master mix (Applied Biosystems, Beverly, MA, USA) and gene-specific
primers listed in Supplemental Table S1. Reported results consist of levels of target mRNA
normalized to β-actin. Data represent the average of biological samples (n = 3–4 mice)
calculated from technical qPCR triplicates.
2.5. Statistics
To determine significance between experimental groups, comparisons were made
using Student’s t-test. Analyses across multiple groups were made using a one-way analysis
of variance with Bonferroni’s post hoc test using GraphPad Prism for Mac (GraphPad
Software, La Jolla, CA, USA) with significance set at p < 0.05.
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edges. Orange dashed lines define the border between the wound bed and subcutaneous white adipose tissue (SWAT).
Scale bars, 250 µm. n = 4 for each condition. Error bars indicate mean ± SEM. * p < 0.05, *** p < 0.001.
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3.2. Fibroblast Heterogeneity Is Altered in Diabetic Wound Beds
While a reduction in proliferation phase myofibroblasts has been documented in
wound beds from diabetic mice [28], little is known about how individual subsets of myofibroblasts are altered by diabetes. We have previously described multiple subsets of
myofibroblasts that can be identified using cell surface marker expression of CD29, SCA1,
and CD34 [23,41]. These myofibroblast subsets are functionally distinct, with different
propensities to generate and modify ECM [23]. In particular, a subset of myofibroblasts
enriched with CD34, SCA1, and CD26 is associated with efficient wound healing, whereas
SCA1-; CD29High myofibroblasts were associated with impaired healing [23]. Using flow
cytometry, we investigated if diabetes alters the relative abundance of CD34+; SCA1+, and
CD29High mesenchymal cells in the skin and determined if colocalization with profibrotic
markers CD9 [47] and CD26 [22] was different in db/db skin compared to db/+ control skin
(Figure S1A). We did not observe a statistically significant difference in the relative abundance of CD34+; SCA1+ and CD29High mesenchymal cells in uninjured skin (Figure 2A),
and the percentage that colocalized with CD9 was similar in diabetic and control samples
(Figure S1B). Interestingly, a greater percentage of CD29High cells colocalized with the
profibrotic marker CD26 in uninjured db/db skin versus uninjured db/+ skin (Figure 2A).
While these mesenchymal cell populations colocalize with markers of profibrotic fibroblasts,
very few cells in intact db/db or control skin express the PU.1 transcription factor that is
expressed by activated profibrotic fibroblasts [48] (Figure S1B), suggesting that diabetic
skin fibroblasts are not in an active fibrotic transcriptional state. Additionally, inherent
differences in gene expression between CD29High and CD34+; SCA1+ fibroblasts are similar
in db/db skin compared to what is observed in other control mouse strains [23], such as
CD34+; SCA1+ fibroblasts expressing higher levels of Ccl2 and Il6 with lower expression
of Il1b and Pdgfa, compared to CD29High fibroblasts (Figure S1C). These data indicate that
diabetic skin is not depleted of fibrogenic fibroblasts prior to the injury.
To determine how diabetes alters the composition of wound bed myofibroblasts, we
examined the relative abundance of CD34+; SCA1+, and CD29High myofibroblast subsets
in wound beds five days post-wounding (PW) in db/+ and db/db mice. Interestingly,
wound beds from diabetic mice exhibited a ~25% greater enrichment for CD29High cells and
lacked significant enrichment for CD34+; SCA1+ myofibroblasts compared to control mice
(Figure 2B,C). These results were similar to what we have previously observed in wounds
from aged mice [23], which also are associated with delayed myofibroblast population
and impaired wound healing. After the injury, a greater percentage of CD34+; SCA1+
myofibroblasts express CD9 while retaining colocalization with CD26. The percentage of
CD34+; SCA1+, and CD29High myofibroblasts that colocalize with CD9 and CD26 was
similar in diabetic and control mice, except more CD29High myofibroblasts colocalize with
CD26 (Figure S1D), similar to what is observed in uninjured skin (Figure 2A). In line with
samples from uninjured skin (Figure S1C) and our previously published data [23], CD34+;
SCA1+ and CD29High wound bed myofibroblasts had unique gene expression profiles. For
instance, CD34+; SCA1+ myofibroblasts had greater expression of Fgf7, Fn1, and Il6, while
CD29High myofibroblasts had greater expression of Pdgfa and Tnc (Figure S1E), suggesting
a functional difference between myofibroblast subsets.
In wild-type strain mice, CD29High myofibroblasts are typically biased to the superficial wound edges [23]. To determine if there are spatial biases to the distribution of
CD34+; SCA1+; CD26+ and CD29High myofibroblasts in db/db mouse wound beds, we
assessed the distribution of nonimmune (CD45 negative) cells in wound beds based on
the expression of CD29 and CD26 in wounds from db/+ and db/db mice (Figure 2D).
Similar to wild-type strains, we observed a superficial and wound edge bias of CD29High
myofibroblasts in wound beds five days PW (Figure 2E). Interestingly, while there was
a delay in CD26-expressing myofibroblasts populating the wound beds of db/db mice,
the spatial distribution mirrored that of db/+ at earlier time points (Figure 2E). While
there is a clear reduction in the abundance of myofibroblasts seven days PW in wounds
of diabetic mice compared to earlier time points in control mice (Figure 1A), there was a
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Figure 3. Dysfunctional myofibroblast gene expression is ameliorated during the proliferation phase of repair. (A,B) Tissue
sections from wound beds five days post-wounding (PW) harvested from db/+ (A) and db/db mice (B) immunostained for
PU.1. Scale bars, 250 µm for low magnification images and 75 µm for high magnification images. (C) Quantification of the
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density of PU.1+ cells and percentage of DAPI+ nuclei in tissue sections from db/+ and db/db wound beds five days PW.
Arrows indicate CD26+; PU.1+ cells, white arrowheads indicate CD26-; PU.1+ cells, and yellow arrowheads indicate CD26+;
PU.1- cells. (D) Image from the center of a day five wound bed immunostained for CD26 and PU.1. Scale bars, 75 µm. (E,F)
Quantification of gene expression of CD34; SCA1+ and CD29High myofibroblasts from db/db mice five days (E) and seven
days (F) PW normalized to the same myofibroblast population from db/+ wounds from the same time point. n = 3–6 for
each condition. Error bars indicate mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001.

To interrogate how diabetes impacts the function of specific myofibroblast subsets,
we FACS-isolated CD34+; SCA1+ and CD29High myofibroblasts from wound beds five
days PW and examined the expression of genes related to myofibroblast function. We
did not observe diabetes-associated changes in gene expression of cellular identity genes,
such as Itga5, Ly6a (SCA1), and Thy1; however, diabetes was associated with changes in
gene expression of ECM- and inflammation-related genes. Interestingly, gene expression
of ECM components, such as Col1, Col3, Fn1, Mmp2, and Tnc, was significantly reduced
in diabetic CD34+; SCA1+ myofibroblasts compared to db/+ controls; however, gene
expression in ECM molecules was not significantly altered in CD29High myofibroblasts
from db/db mice (Figure 3E). We further explored ECM components through analysis
of tissue sections in uninjured skin and wound beds. While tenascin C is not present
in uninjured skin, we observed reduced immunofluorescent staining of fibronectin in
db/db skin compared to db/+ skin (Figure S2A,B). Interestingly, after injury, the relative
intensity of fibronectin staining is similar between db/db and db/+ mice (Figure S2C,D),
and tenascin C levels are lower in db/db wounds compared to db/+ controls at both five
and seven days PW (Figure S2E,F). These results are in line with our observed changes
in gene expression and previous reports demonstrating that diabetes is associated with
normal levels of fibronectin [32] but decreased levels of tenascin C after injury.
To further explore how diabetes alters fibroblast function during the proliferation
phase, we examined gene expression of ECM molecules and secreted signaling molecules
in SCA1+ and CD29High myofibroblasts seven days after injury. Surprisingly, we observed few significant changes in gene expression within the SCA1+ myofibroblast subset
(Figure 3F). While we observe reduced ECM molecule expression in CD29High myofibroblasts (Figure 3F), many of these genes are more enriched in CD34; SCA1+ myofibroblasts
(Figure S1D) [23]. These data indicate that diabetes-associated changes in gene expression
are less pronounced in CD34+; SCA1+ myofibroblasts at the same time post-wounding as
when the number of CD34+; SCA1+; CD26+ myofibroblasts increases (Figure 2C,E).
3.4. A Macrophage Phenotype Switch Is Concomitant with Changes in Wound Bed Myofibroblasts
Our data reveal a similar gene expression profile in SCA1+ myofibroblasts and a
correction of myofibroblast heterogeneity seven days after injury in our wound model
(Figure 2C). This indicates that the wound environment of db/db mice is capable of
rescuing CD34+; SCA1+ myofibroblast dysfunction prior to the rapid recovery in general myofibroblast population and tissue formation that is observed by two weeks after
injury in db/db mice (Figure 1A–D). Macrophage phenotype has been correlated with
fibroblast function and wound healing outcomes in humans [40,51–54], and functional
animal studies have confirmed that anti-inflammatory (M2) macrophages support tissue
repair [17,46,55,56]. After the injury, iNOS+ inflammatory (M1) macrophages are prevalent
during the early phases of repair. As healing proceeds, the number of M1 macrophages
decreases as CD206+ M2 macrophages become the predominant phenotype. Over time,
CD206+ macrophages begin to express CD301b [46,57]. To define changes in macrophage
phenotype that are associated with rescued myofibroblast heterogeneity and function, we
quantified the number of CD206+, CD310b+, and iNOS+ macrophages in tissue sections
during tissue repair in db/+ and db/db mice (Figure 4A–C). Diabetic mice had fewer
CD206+ and CD301b+ M2 macrophages and a greater number of iNOS + M1 macrophages
five days PW. Interestingly, the relative numbers of CD206+ and iNOS+ macrophages were
not significantly different seven days after injury, corresponding with the timing of rescued
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By seven days PW, the relative abundance of CD26+ cells in db/db mouse wound beds
positively correlated with SMA+, ER-TR7+ and CD301b+ cell numbers (Figure 5C). These
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data provide a disease context to strengthen the previously published connection between
CD301b+ macrophages and fibrogenic CD26+ myofibroblasts [23].
4. Discussion
Progression of tissue repair into the proliferation phase has been linked to a switch
in macrophage polarization [10,40,46,51], as anti-inflammatory macrophages initiate repair. Here, we revealed that diabetic mouse wounds have both fewer myofibroblasts with
fibrogenic capacity and impaired gene expression within myofibroblast subsets. Collectively, these changes contribute to diminished ECM production during diabetic wound
healing [32,58]. Our 4 mm biopsy punch model of dorsal skin excision enables more rapid
recovery of wound healing defects than larger wound paradigms. This allowed us to
capture a time point in diabetic wound healing when myofibroblast numbers are still
reduced compared to controls; however, the relative abundance of myofibroblast subsets
and repair-related gene expression within each subset are not significantly different. Correlation analysis revealed that efficient wound healing in control mice is associated with
CD206-expressing anti-inflammatory (M2) macrophages. This same analysis identified
that the ability of diabetic mouse wounds to rescue the impaired healing phenotype is not
associated with CD206+ macrophages but with CD301b-expressing macrophages. These
macrophages have been shown to be important for the expansion of fibrogenic wound
myofibroblasts and efficient wound healing [23,46]. These findings are supported by animal studies that demonstrated that amelioration of impaired healing could occur through
administration of (1) factors that rescue defects in early macrophage infiltration [16,59–61]
or (2) factors derived from anti-inflammatory macrophages that promote repair [23,62–67].
These data not only describe how diabetes alters myofibroblast composition and gene
expression but also differences in how wound healing in control and diabetic animals
may rely on subtle differences in anti-inflammatory macrophage subsets to support tissue
repair.
Recently, single-cell RNA-sequencing has been used to define the cellular composition
in human diabetic skin and wound samples [39,40,68]. These studies provide tremendous
insights into cellular heterogeneity and changes in gene expression between conditions;
however, additional time points throughout the healing process are needed to fully understand how the environment changes over time. This challenge is compounded by the
inability to identify a chronic or nonhealing wound patient until months after the injury [33].
At this late time point after injury, the cellular and molecular interactions dictating local
cellular responses are different than what is observed during normal acute repair [28]. Using a 4 mm dorsal skin excision wound model, we examined repair at multiple time points
during the proliferation phase to define how myofibroblast heterogeneity is altered in
db/db mice compared to db/+ control animals. The lack of CD26+; SCA1+ fibroblasts early
during the proliferation phase is consistent with what is observed with age [23,69]. Later
during the proliferation phase, CD26+; SCA1+ myofibroblasts become more abundant
than other myofibroblast subsets in diabetic wounds. This change is observed alongside
a recovery in impaired myofibroblast gene expression but prior to a broader rescue of
total myofibroblast numbers, suggesting that the wound environment can rescue impaired
healing in diabetic mice. Performing transcriptomics at multiple time points throughout the
healing process would allow future studies to explore mechanisms necessary to overcome
the diabetic environment and contribute to new therapeutic approaches.
Analyzing multiple parameters in tissue sections from the center of the same wound
beds allowed us to determine cellular events associated with improved outcomes at multiple time points. This comprehensive correlation analysis revealed that diabetic wounds
with greater myofibroblast abundance, including more fibrogenic CD26+ myofibroblasts,
correlated with greater numbers of CD301b+ macrophages at both five and seven days
after injury. While this is in line with other reports [23,26,46,70], the correlation was not
detectable in our data that averaged numbers within a group, a surprising result, given
that CD301b+ cell numbers were low in 5- and 7-day wound beds from db/db mice with
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minimal variation between animals. This result reveals that averaging data groups is
susceptible to losing valuable data based on the variation within a group. Additionally,
our correlation analyses revealed that different M2 macrophage populations were associated with improved myofibroblast numbers in diabetic versus control groups. Recently,
increased attention has been given to experiments aimed at defining mechanisms that support diabetic healing in humans [39,40]. Researchers have started to rely less on data from
lean individuals and more on samples from diabetic healers as controls for studies examining impaired diabetic wound healing [5,39]. Our correlation analyses capitalized on the
variation that occurs during diabetic wound healing in mice to reveal conditions associated
with improved myofibroblast repopulation relative to wounds with more myofibroblast
dysfunction. Additional studies will be needed to determine if CD301b+ macrophages
functionally contribute to the corrected myofibroblast phenotypes during delayed diabetic
wound healing.
5. Conclusions
In summary, while murine diabetic wound healing is associated with fewer profibrotic
myofibroblasts and decreased expression of genes associated with the repair, diabetic
wounds that can heal have greater numbers of CD301b-expressing macrophages. It will
be important for future investigations to determine how factors influence the ability of
myofibroblasts to recovery, especially since the length of diabetes, size of the wound, or
animal species can impact healing rates [34,44,45,71]. Additionally, it will be critical to
determine if the same cellular and molecular mechanisms are responsible for the recovery
in different injury paradigms since slight changes in wound size can substantially impact
the contribution from specific fibroblast lineages and regenerative potential of the injury
response [24,37,41,72,73]. Since diabetic human fibroblasts undergo epigenetic changes
that are not easily rescued in culture [74], future studies are needed that explore differences
in diabetic healers and diabetic non-healers. Future human studies will be critical for
uncovering clinically relevant mechanisms that promote myofibroblast function and tissue
repair in diabetics.
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